XOMA's (XOMA) Buy Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of XOMA (NASDAQ:XOMA – Free Report) in a research report released on Wednesday, Benzinga reports. HC Wainwright currently has a $74.00 price target on the biotechnology company’s stock. Separately, SVB Leerink assumed coverage on shares of XOMA in a report on Monday, April 29th. They set an […]